BM8-18213-43883
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 021 / MA
- Registered
- 2021-12-29
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-12-29
Registered in v-safe
-
2021-12-29
Dose 3 — Moderna
- 2021-12-30
-
2021-12-31
Survey response — days 1–6 daily, dose 3MedDRA: Asthenia, Dizziness — Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Felt dizzy and weak last night repetitively. Had to lay down in between trying to complete tasksMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | No |
| 2 | 2021-01-13 | Pfizer-BioNTech | No |
| 3 | 2021-12-29 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Felt dizzy and weak last night repetitively. Had to lay down in between trying to complete tasks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthenia | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release